Emmanuel G. Fragoulis
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome.
Journal: Diabetes research and clinical practice
Published: July 04, 2019
Decreased expression of microRNAs targeting type-2 diabetes susceptibility genes in peripheral blood of patients and predisposed individuals.
Journal: Endocrine
Published: June 14, 2019
Blood-based analysis of type-2 diabetes mellitus susceptibility genes identifies specific transcript variants with deregulated expression and association with disease risk.
Journal: Scientific reports
Published: June 27, 2018
Clinical evaluation of microRNA-145 expression in renal cell carcinoma: a promising molecular marker for discriminating and staging the clear cell histological subtype.
Journal: Biological chemistry
Published: November 23, 2015
Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment.
Journal: Carcinogenesis
Published: March 26, 2015
L-DOPA decarboxylase mRNA levels provide high diagnostic accuracy and discrimination between clear cell and non-clear cell subtypes in renal cell carcinoma.
Journal: Clinical biochemistry
Published: December 22, 2014
Human L-DOPA decarboxylase mRNA is a target of miR-145: A prediction to validation workflow.
Journal: Gene
Published: July 28, 2014
Quantification and study of the L-DOPA decarboxylase expression in gastric adenocarcinoma cells treated with chemotherapeutic substances.
Journal: Anti-cancer drugs
Published: January 19, 2013
L-Dopa decarboxylase (DDC) constitutes an emerging biomarker in predicting patients' survival with stomach adenocarcinomas.
Journal: Journal of cancer research and clinical oncology
Published: July 16, 2012
Effect of cytostatic drugs on the mRNA expression levels of ribonuclease κ in breast and ovarian cancer cells.
Journal: Anti-cancer agents in medicinal chemistry
Published: July 04, 2012
l-DOPA Decarboxylase (DDC) Expression Status as a Novel Molecular Tumor Marker for Diagnostic and Prognostic Purposes in Laryngeal Cancer.
Journal: Translational oncology
Published: June 20, 2012
Last Updated: 09/26/2026